Back to top

ELVN Maintained by Goldman Sachs -- Price Target Raised to $67.00

ELVN Maintained by Goldman Sachs -- Price Target Raised to $67.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)